False
October 9, 2025
By Jessica Allerton
The discovery of millions of Arab-specific variants shows why inclusive genomics is essential for equity in diagnosis and precision medicine
4 min read
October 7, 2025
First biomarker-driven randomized trial in non-metastatic prostate cancer underscores the diagnostic potential of molecular assays
1 min read
October 3, 2025
By Helen Bristow
Osama Khan, Anatomical Pathologist at Natera, shares his motivations for switching from academia to industry and carving out a career at the forefront of molecular testing and innovation
6 min read
September 30, 2025
By Jessica Allerton
Following a new CAP review, Jason L. Hornick discusses the strengths – and limitations – of IHC as a stand-in for molecular testing
4 min read
September 23, 2025
TruSight™ Oncology 500 v2 (TSO500v2) is an updated next-generation sequencing (NGS) assay designed to enable laboratories with in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue samples...
12:00 pm - 1:00 pm GMT-4 min read
September 18, 2025
By Helen Bristow
With millions of contextualized patient data records now available across oncology, clinical development needs to evolve for the precision medicine era, says Gen Li
6 min read
September 12, 2025
By Kathryn Wighton
An analysis of breast cancer cases found human epidermal growth factor receptor-2 messenger RNA scores correlated with immunohistochemistry but did not replace standard testing
1 min read
September 9, 2025
How a single-cell proteomics test, run on a standard pathology slide, can reshape treatment decisions
4 min read
September 5, 2025
By Kathryn Wighton
New lab personnel role could help improve and standardize testing for precision medicine in oncology
1 min read
September 2, 2025
Study evaluates ctDNA for measurable residual disease testing in large B-cell lymphoma
1 min read
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False